Insulet (PODD) Other Non-Current Liabilities (2010 - 2026)
Insulet's (PODD) quarterly Other Non-Current Liabilities came in at $69.2 million in Q2 2026, up 21.19% on a YoY basis from $57.1 million in Q2 2025, and up 2.22% quarter-over-quarter from $67.7 million in Q1 2026.
Analysis
Insulet (PODD) Other Non-Current Liabilities (2010 - 2026) Analysis & Trends
Insulet (PODD) has reported Other Non-Current Liabilities for 17 consecutive years, with $69.2 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Other Non-Current Liabilities rose 21.19% year-over-year to $69.2 million; the trailing twelve-month figure through Jun 2026 stood at $69.2 million (up 21.19% YoY), and the FY2025 full-year result was $64.4 million, up 24.56% from the prior year.
- Other Non-Current Liabilities climbed to $69.2 million in Q2 2026 per PODD's latest filing, from $67.7 million in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $69.2 million in Q2 2026 and bottomed at $17.0 million in Q1 2022.
- Historically, Other Non-Current Liabilities has averaged $44.4 million across 5 years, with a median of $38.3 million in 2023.
- The widest YoY moves for Other Non-Current Liabilities: up 139.6% in 2022, down 3.95% in 2022.
- Over 5 years, Other Non-Current Liabilities stood at $35.7 million in 2022, then advanced by 6.16% to $37.9 million in 2023, then soared by 36.41% to $51.7 million in 2024, then increased by 24.56% to $64.4 million in 2025, then climbed by 7.45% to $69.2 million in 2026.
- According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $69.2 million, $67.7 million, and $64.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 69.20 Mn |
| Mar 31, 2026 | 67.70 Mn |
| Dec 31, 2025 | 64.40 Mn |
| Sep 30, 2025 | 62.60 Mn |
| Jun 30, 2025 | 57.10 Mn |
| Mar 31, 2025 | 53.90 Mn |
| Dec 31, 2024 | 51.70 Mn |
| Sep 30, 2024 | 44.90 Mn |
| Jun 30, 2024 | 37.30 Mn |
| Mar 31, 2024 | 38.30 Mn |
| Dec 31, 2023 | 37.90 Mn |
| Sep 30, 2023 | 38.20 Mn |
| Jun 30, 2023 | 38.30 Mn |
| Mar 31, 2023 | 34.20 Mn |
| Dec 31, 2022 | 35.70 Mn |
| Sep 30, 2022 | 24.20 Mn |
| Jun 30, 2022 | 26.80 Mn |
| Mar 31, 2022 | 17.00 Mn |
| Dec 31, 2021 | 14.90 Mn |
| Sep 30, 2021 | 15.40 Mn |